Insights into iron and nuclear factor-kappa B (NF-κB) involvement in chronic inflammatory processes in peritoneal endometriosis

Histology and Histopathology

Volumn 26, Issue 8, 2011, Pages 1083-1092

  Defrère, Sylvie ^a   González Ramos, Reinaldo ^b   Lousse, Jean Christophe ^a   Colette, Sébastien ^a   Donnez, Olivier ^a   Donnez, Jacques ^a   Van Langendonckt, Anne ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b HOSPITAL SAN BORJA ARRIARÁN   (Chile)

Author keywords

Endometriosis; Inflammation; Iron; Macrophage; NF kappaB

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON DERIVATIVE; REACTIVE OXYGEN METABOLITE;

CHRONIC DISEASE; ENDOMETRIOSIS; FEMALE; HUMAN; INFLAMMATION; IRON OVERLOAD; METABOLISM; PATHOLOGY; PERITONEAL DISEASE; PERITONEUM; REVIEW;

CHRONIC DISEASE; ENDOMETRIOSIS; FEMALE; HUMANS; INFLAMMATION; IRON COMPOUNDS; IRON OVERLOAD; NF-KAPPA B; PERITONEAL DISEASES; PERITONEUM; REACTIVE OXYGEN SPECIES;

EID: 80053201966     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. Aggarwal B.B. (2004). Nuclear factor-κB: the enemy within. Cancer Cell 6, 203-208.
2. Agic A., Xu H., Finas D., Banz C., Diedrich K. and Hornung D. (2006). Is endometriosis associated with systemic subclinical inflammation? Gynecol. Obstet. Invest. 62, 139-147.
3. Arumugam K. (1994). Endometriosis and infertility: raised iron concentration in the peritoneal fluid and its effect on the acrosome reaction Hum. Reprod. 9, 1153-1157.
4. Arumugam K. and Lim J.M. (1997). Menstrual characteristics associated with endometriosis. Br. J. Obstet. Gynaecol. 104, 948-950.
5. Arumugam K. and Yip Y.C. (1995). De novo formation of adhesions in endometriosis: the role of iron and free radical reactions. Fertil. Steril. 64, 62-64.
6. Baldwin A.S. (2001). Control of oncogenesis and cancer therapy resistance by the transcription factor NFκB. J. Clin. Invest. 107, 241-246.
7. Balla G., Jacob H.S., Balla J., Rosenberg M., Nath K., Apple F., Eaton J.W. and Vercellotti G.M. (1992). Ferritin: a cytoprotective antioxidant strategem of endothelium. J. Biol. Chem. 267, 18148-18153.
8. Barnes P.J. (1997). Nuclear factor-kappa B. Int. J. Biochem. Cell. Biol. 29, 867-870.
9. Barrier B.F. (2010). Immunology of endometriosis. Clin. Obstet. Gynecol. 53, 397-402.
10. Bedaiwy M.A. and Falcone T. (2003). Peritoneal fluid environment in endometriosis. Clinicopathological implications. Minerva Ginecol. 55, 333-345.
11. Béliard A., Donnez J., Nisolle M. and Foidart J.M. (1997). Localization of laminin, fibronectin, E-cadherin, and integrins in endometrium and endometriosis. Fertil. Steril. 67, 266-272.
12. Beliard A., Noel A. and Foidart J.M. (2004). Reduction of apoptosis and proliferation in endometriosis. Fertil. Steril. 82, 80-88.
13. Bridges J.E., Prentice A., Roche W., Englefield P. and Thomas E.J. (1994). Expression of integrin adhesion molecules in endometrium and endometriosis. Br. J. Obstet. Gynaecol. 101, 696-700.
14. Bruner K.L., Matrisian L.M., Rodgers W.H., Gorstein F. and Osteen K.G. (1997). Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J. Clin. Invest. 99, 2851-2857.
15. Cao W.G., Morin M., Metz C., Maheux R. and Akoum A. (2005). Stimulation of macrophage migration inhibitory factor expression in endometrial stromal cells by interleukin 1, beta involving the nuclear transcription factor NFκB. Biol. Reprod. 73, 565-570.
16. Cao W.G., Morin M., Sengers V., Metz C., Roger T., Maheux R. and Akoum A. (2006). Tumour necrosis factor-a upregulates macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NF-kB. Hum. Reprod. 21, 421-428.
17. Casanas-Roux F., Van Langendonckt A., Dolmans M.M. and Donnez J. (2002). Expression of inducible heme oxygenase in human endometrium. Fertil. Steril. 78, 1327-1238.
18. Celik O., Hascalik S., Elter K., Tagluk M.E., Gurates B. and Aydin N.E. (2008). Combating endometriosis by blocking proteasome and nuclear factor-κB pathways. Hum. Reprod. 23, 2458-2465.
19. Chen S.U., Lee H., Chang D.Y., Chou C.H., Chang C.Y., Chao K.H., Lin C.W. and Yang Y.S. (2008). Lysophosphatidic acid mediates interleukin-8 expression in human endometrial stromal cells through its receptor and nuclear factor-κB dependent pathway: a possible role in angiogenesis of endometrium and placenta. Endocrinology 149, 5888-5896.
20. Cramer D.W., Wilson E., Stillman R.J., Berger M.J., Belisle S., Schiff I., Albrecht B., Gibson M., Stadel B.V. and Schoenbaum S.C. (1986). The relation of endometriosis to menstrual characteristics, smoking, and exercise. JAMA 255, 1904-1908.
21. Crichton R.R., Wilmet S., Legssyer R. and Ward R.J. (2002). Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J. Inorg. Biochem. 91, 9-18.
22. Dalton T.P., Shertzer H.G. and Puga A. (1999). Regulation of gene expression by reactive oxygen. Annu. Rev. Pharmacol. Toxicol. 39, 67-101.
23. Darrow S.L., Vena J.E., Batt R.E., Zielezny M.A., Michalek A.M. and Selman S. (1993) Menstrual cycle characteristics and the risk of endometriosis. Epidemiology 4, 135-142.
24. Dassen H., Kamps R., Punyadeera C., Dijcks F., de Goeij A., Ederveen A., Dunselman G. and Groothuis P. (2008). Haemoglobin expression in human endometrium. Hum. Reprod. 23, 635-641.
25. Defrère S., Donnez J., Moulin P., Befahy P., González-Ramos R., Lousse J.C. and Van Langendonckt A. (2007). Expression of intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 in human endometrial stromal and epithelial cells is regulated by interferon-gamma (IFN-γ) but not iron. Gynecol. Obstet. Invest. 65, 145-154.
26. Defrère S., Van Langendonckt A., Vaesen S., Jouret M., González-Ramos R., Gonzalez D. and Donnez J. (2006). Iron overload enhances epithelial cell proliferation in endometriotic lesions induced in a murine model. Hum. Reprod. 21, 2810-2816.
27. Defrère S., Lousse J.C., González-Ramos R., Colette S., Donnez J. and Van Langendonckt A. (2008). Potential involvement of iron in the pathogenesis of peritoneal endometriosis. Mol. Hum. Reprod. 14, 377-85.
28. Demir A.Y., Groothuis P.G., Nap A.W., Punyadeera C., de Goeij A.F., Evers J.L. and Dunselman G.A. (2004). Menstrual effluent induces epithelial-mesenchymal transitions in mesothelial cells. Hum. Reprod. 19, 21-29.
29. D'Hooghe T.M. and Debrock S. (2002). Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons. Hum. Reprod. Update 8, 84-88.
30. Donnez J., Smoes P., Gillerot S., Casanas-Roux F. and Nisolle M. (1998). Vascular endothelial growth factor (VEGF) in endometriosis. Hum. Reprod. 13, 1686-1890.
31. Dunselman G.A. (1995). Peritoneal environment in endometriosis. In: Endometriosis: current understanding and management. Shaw R.W. (ed). Blackwell Science. Oxford. pp 47-74.
32. Dunselman G.A., Groothuis P.G., de Goeij A.F. and Evers J.L. (2001). The mesothelium, teflon or velcro? Mesothelium in endometriosis pathogenesis. Hum. Reprod. 16, 605-607.
33. Dunselman G.A., Hendrix M.G., Bouckaert P.X. and Evers J.L. (1988). Functional aspects of peritoneal macrophages in endometriosis of women. J. Reprod. Fertil. 82, 707-710.
34. Farina A.R., Tacconelli A., Vacca A., Maroder M., Gulino A. and Mackay A.R. (1999). Transcriptional upregulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GTbox and nuclear factor kB elements. Cell Growth Differ. 10, 353-367.
35. Gaulier A., Jouret-Mourin A. and Marsan C. (1983). Peritoneal endometriosis. Report of a case with cytologic, cytochemical and histopathologic study. Acta Cytol. 27, 446-449.
36. Gazvani R. and Templeton A. (2002). Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 123, 217-226.
37. Giudice L.C. and Kao L.C. (2004). Endometriosis. Lancet 364, 789-799.
38. González-Ramos R., Donnez J., Defrère S., Leclercq I., Squifflet J., Lousse J.C. and Van Langendonckt A. (2007). Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis. Mol. Hum. Reprod. 13, 503-509.
39. González-Ramos R., Van Langendonckt A., Defrère S., Lousse J.C., Mettlen M., Guillet A. and Donnez J. (2008). Agents blocking the nuclear factor-kappaB pathway are effective inhibitors of endometriosis in an in vivo experimental model. Gynecol. Obstet. Invest. 65, 174-186.
40. González-Ramos R., Van Langendonckt A., Defrère S., Lousse J.C., Colette S., Devoto L. and Donnez J. (2010). Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis. Fertil. Steril. 94, 1985-1994.
41. Grumont R.J., Rourke I.J., O'Reilly L.A., Strasser A., Miyake K., Sha W. and Gerondakis S. (1998). B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogenactivated cells. J. Exp. Med. 187, 663-674.
42. Grund E.M., Kagan D., Tran C.A., Zeitvogel A., Starzinski-Powitz A., Nataraja S. and Palmer S.S. (2008). Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogenactivated protein kinase kinase, p38, and nuclear factor kB in human endometriotic epithelial cells. Mol. Pharmacol. 73, 1394-1404.
43. Guo S.W. (2007). Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? Gynecol. Obstet. Invest. 63, 71-97.
44. Gupta S., Agarwal A., Sekhon L., Krajcir N., Cocuzza M. and Falcone T. (2006). Serum and peritoneal abnormalities in endometriosis: potential use as diagnostic markers. Minerva Ginecol. 58, 527-551.
45. Halme J., Hammond M.G., Hulka J.F., Raj S.G. and Talbert L.M. (1984). Retrograde menstruation in healthy women and in patients with endometriosis. Obstet. Gynecol. 64, 151-154.
46. Halme J., Becker S. and Haskill S. (1987). Altered maturation and function of peritoneal macrophages: possible role in pathogenesis of endometriosis. Am. J. Obstet. Gynecol. 156, 783-89.
47. Harada T., Kaponis A., Iwabe T., Taniguchi F., Makrydimas G., Sofikitis N., Paschopoulos M., Paraskevaidis E. and Terakawa N. (2004). Apoptosis in human endometrium and endometriosis. Hum. Reprod. Update 10, 29-38.
48. Harada T., Iwabe T. and Terakawa N. (2001). Role of cytokines in endometriosis. Fertil. Steril. 76, 1-10.
49. Heilier J.F., Donnez J. and Lison D. (2008). Organochlorines and endometriosis: a mini-review. Chemosphere 71, 203-10.
50. Horie S., Harada T., Mitsunari M., Taniguchi F., Iwabe T. and Terakawa N. (2005). Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kB inactivation in endometriotic stromal cells. Fertil. Steril. 83, 1530-1535.
51. Iizuka M., Igarashi M., Abe Y., Ibuki Y., Koyasu Y. and Ikuma K. (1998) Chemical assay of iron in ovarian cysts: a new diagnostic method to evaluate endometriotic cysts. Gynecol. Obstet. Invest. 46, 58-60.
52. Jackson L.W., Schisterman E.F., Dey-Rao R., Browne R. and Armstrong D. (2005) Oxidative stress and endometriosis. Hum. Reprod. 20, 2014-2020.
53. Karin M. (2006). Nuclear factor-κB in cancer development and progression. Nature 441, 431-436.
54. Kartikasari A.E.R., Georgiou N.A., Visseren F.L.J., van Kats-Renaud H., van Asbeck B.S. and Marx J.J.M. (2004) Intracellular labile iron modulates adhesion of human monocytes to human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 24, 2257-2262.
55. King A.E., Critchley H. and Kelly R.W. (2001). The NF-κB pathway in human endometrium and first trimester decidua. Mol. Hum. Reprod. 7, 175-183.
56. Knutson M. and Wessling-Resnick M. (2003) Iron metabolism in the reticuloendothelial system. Crit. Rev. Biochem. Mol. Biol. 38, 61-88.
57. Kobayashi H., Yamada Y., Kanayama S., Furukawa N., Noguchi T., Haruta S., Yoshida S., Sakata M., Sado T. and Oi H. (2009). The role of iron in the pathogenesis of endometriosis. Gynecol. Endocrinol. 25, 39-52.
58. Kokorine I., Nisolle M., Donnez J., Eeckhout Y., Courtoy P.J. and Marbaix E. (1997). Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions. Fertil. Steril. 68, 246-251.
59. Kristiansen M., Graversen J.H., Jacobsen C., Sonne O., Hoffman H.J., Law S.K. and Moestrup S.K. (2001). Identification of the haemoglobin scavenger receptor. Nature 409, 198-201.
60. Laird S.M., Tuckerman E.M., Cork B.A. and Li T.C. (2000). Expression of nuclear factor k B in human endometrium; role in the control of interleukin 6 and leukaemia inhibitory factor production. Mol. Hum. Reprod. 6, 34-40.
61. Lawrence T., Gilroy D.W., Colville-Nash P.R. and Willoughby D.A. (2001). Possible new role for NF-kB in the resolution of inflammation. Nat. Med. 7, 1291-1297.
62. Le N.T. and Richardson D.R. (2002). The role of iron in cell cycle progression and the proliferation of neoplasic cells. Biochim. Biophys. Acta 1603, 31-46.
63. Lebovic D.I., Chao V.A., Martini J.F. and Taylor R.N. (2001). IL-1ß induction of RANTES (regulated upon activation, normal T cell expressed and secreted) chemokine gene expression in endometriotic stromal cells depends on a nuclear factor-κB site in the proximal promoter. J. Clin. Endocrinol. Metab. 86, 4759-47064.
64. Lebovic D.I., Mueller M.D. and Taylor R.N. (2001). Immunobiology of endometriosis. Fertil. Steril. 75, 1-10.
65. Lousse J.C., Van Langendonckt A., González-Ramos R., Defrère S., Renkin E. and Donnez J. (2008). Increased activation of nuclear factor-kappa B (NF-kappaB) in isolated peritoneal macrophages of patients with endometriosis. Fertil. Steril. 90, 217-220.
66. Lousse J.C., Defrère S., Van Langendonckt A., Gras J., González-Ramos R., Colette S. and Donnez J. (2009). Iron storage is significantly increased in peritoneal macrophages of endometriosis patients and correlates with iron overload in peritoneal fluid. Fertil. Steril. 91, 1668-1675.
67. Lousse J.C., Defrère S., Colette S., Van Langendonckt A. and Donnez J. (2010). Expression of eicosanoid biosynthetic and catabolic enzymes in peritoneal endometriosis. Hum. Reprod. 25, 734-741.
68. Mathur S.P., Lee J.H., Jiang H., Arnaud P. and Rust P.F. (1999). Levels of transferrin and alpha 2-HS glycoprotein in women with and without endometriosis. Autoimmunity 29, 121-127.
69. McLaren J. (2000). Vascular endothelial growth factor and endometriotic angiogenesis. Hum. Reprod. Update 6, 45-55.
70. Mizuuchi H., Kudo R., Tamura H., Tsukahara K., Tsumura N., Kumai K. and Sato K. (1988). Identification of transferrin receptor in cervical and endometrial tissues. Gynecol. Oncol. 31, 292-300.
71. Moen M.H. and Halvorsen T.B. (1992). Histologic confirmation of endometriosis in different peritoneal lesions. Acta Obstet. Gynecol. Scand. 71, 337-342.
72. Montagna P., Capellino S., Villaggio B., Remorgida V., Ragni N., Cutolo M. and Ferrero S. (2008). Peritoneal fluid macrophages in endometriosis: correlation between the expression of estrogen receptors and inflammation. Fertil. Steril. 90, 156-164.
73. Montgomery G.W., Nyholt D.R., Zhao Z.Z., Treloar S.A., Painter J.N., Missmer S.A., Kennedy S.H. and Zondervan K.T. (2008). The search for genes contributing to endometriosis risk. Hum. Reprod. Update 14, 447-457.
74. Nisolle M., Casanas-Roux F. and Donnez J. (2000). Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice. Fertil. Steril. 74, 306-312.
75. Oral E., Olive D.L. and Arici A. (1996). The peritoneal environment in endometriosis. Hum. Reprod. update 2, 385-98.
76. Perkins N.D. (2007). Integrating cell-signalling pathways with NFkappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49-62.
77. Petrozza V., Magliocca F.M., Pulvirenti S., Massimi G., de Salazar C. and Carpino F. (1993). Asymptomatic peritoneal endometriosis following cesarean section. Minerva Ginecol. 45, 349-353.
78. Piva M. and Sharpe-Timms K.L. (1999). Peritoneal endometriotic lesions differentially express a haptoglobin-like gene. Mol. Hum. Reprod. 5, 71-78.
79. Polak G., Wertel I., Tarkowski R., Morawska D., Nowakowski A. and Kotarski J. (2006). Ferritin levels in the peritoneal fluid--a new endometriosis marker? Ginekol. Pol. 77, 389-393.
80. Polak G., Wertel I., Tarkowski R. and Kotarski J. (2010). Peritoneal fluid iron levels in women with endometriosis. Ginekol. Pol. 81, 20-23.
81. Ponce C., Torres M., Galleguillos C., Sovino H., Boric M.A., Fuentes A. and Johnson M.C. (2009). Nuclear factor kappaB pathway and interleukin-6 are affected in eutopic endometrium of women with endometriosis. Reproduction 137, 727-737.
82. Rana N., Braun D.P., House R., Gebel H., Rotman C. and Dmowski W.P. (1996). Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis. Fertil. Steril. 65, 925-930.
83. Regidor P.A., Vogel C., Regidor M., Schindler A.E. and Winterhager E. (1998). Expression pattern of integrin adhesion molecules in endometriosis and human endometrium. Hum. Reprod. Update 4, 710-718.
84. Rizner T.L. (2009). Estrogen metabolism and action in endometriosis. Mol. Cell. Endocrinol. 307, 8-18.
85. Sakamoto Y., Harada T., Horie S., Iba Y., Taniguchi F., Yoshida S., Iwabe T. and Terakawa N. (2003). Tumor necrosis factor-α-induced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-κB activation: gonadotropinreleasing hormone agonist treatment reduced IL-8 expression. J. Clin. Endocrinol. Metab. 88, 730-735.
86. Salamanca A. and Beltran E. (1995). Subendometrial contractility in menstrual phase visualized by transvaginal sonography in patients with endometriosis. Fertil. Steril. 64, 193-5.
87. Sampson J.A. (1927). Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am. J. Obstet. Gynecol. 14, 422-469.
88. Sanfilippo J.S., Wakim N.G., Schikler K.N. and Yussman M.A. (1986). Endometriosis in association with uterine anomaly. Am. J. Obstet. Gynecol. 154, 39-43.
89. Santanam N., Murphy A.A. and Parthasarathy S. (2002). Macrophages, oxidation, and endometriosis. Ann. N. Y. Acad. Sci. 955, 183-98.
90. Sharpe-Timms K.L., Piva M., Ricke E.A., Surewicz K., Zhang Y.L. and Zimmer R.L. (1998). Endometriotic lesions synthesize and secrete a haptoglobin-like protein. Biol. Reprod. 58, 988-994.
91. Sharpe-Timms K.L., Ricke E.A., Piva M. and Horowitz G.M. (2000). Differential expression and localization of de-novo synthesized endometriotic haptoglobin in endometrium and endometriotic lesions. Hum. Reprod. 15, 2180-5.
92. Sharpe-Timms K.L., Zimmer R.L., Ricke E.A., Piva M. and Horowitz G.M. (2002). Endometriotic haptoglobin binds to peritoneal macrophages and alters their function in women with endometriosis. Fertil. Steril. 78, 810-819.
93. She H., Xiong S., Lin M., Zandi E., Giulivi C. and Tsukamoto H. (2002). Iron activates NF-kB in Kupffer cells. Am. J. Physiol. Gastrointest. Liver Physiol. 283, 719-726.
94. Sidell N., Han S.W. and Parthasarathy S. (2002). Regulation and modulation of abnormal immune responses in endometriosis. Ann. N. Y. Acad. Sci. 955, 159-173.
95. Sillem M., Prifti S., Neher M. and Runnebaum B. (1998). Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis. Hum. Reprod. Update 4, 730-735.
96. Skowron J. (2000). The effect of iron on peritoneal macrophage activity and sperm phagocytosis in rats. Ann. Acad. Med. Stetin. 46, 63-75.
97. Stowell S.B., Wiley C.M., Perez-Reyes N. and Powers C.N. (1997). Cytologic diagnosis of peritoneal fluids. Applicability to the laparoscopic diagnosis of endometriosis. Acta Cytol. 41, 817-822.
98. Sugimura K., Takemori M., Sugiura M., Okizuka H., Kono M. and Ishida T. (1992). The value of magnetic resonance relaxation time in staging ovarian endometrial cysts. Br. J. Radiol. 65, 502-506.
99. Szczepanska M., Kozlik J., Skrzypczak J. and Mikołajczyk M. (2003). Oxidative stress may be a piece in the endometriosis puzzle. Fertil. Steril. 79, 1288-1293.
100. Takahashi K., Okada S., Okada M., Kitao M., Kaji Y. and Sugimura K. (1996). Magnetic resonance relaxation time in evaluating the cyst fluid characteristics of endometrioma. Hum. Reprod. 11, 857-60.
101. Tam T.F., Leung-Toung R., Li W., Wang Y., Karimian K. and Spino M. (2003). Iron chelator research: past, present and future. Curr. Med. Chem. 10, 983-995.
102. Van der Linden P.J., de Goeij A.F., Dunselman G.A., van der Linden E.P., Ramaekers F.C. and Evers J.L. (1994). Expression of integrins and E-cadherin in cells from menstrual effluent, endometrium, peritoneal fluid, peritoneum, and endometriosis. Fertil. Steril. 61, 85-90.
103. Van Langendonckt A., Casanas-Roux F. and Donnez J. (2002a). Oxidative stress and peritoneal endometriosis. Fertil. Steril. 77, 861-870.
104. Van Langendonckt A., Casanas-Roux F., Dolmans M.M. and Donnez J. (2002b). Potential involvement of hemoglobin and heme in the pathogenesis of peritoneal endometriosis. Fertil. Steril. 77, 561-570.
105. Van Langendonckt A., Casanas-Roux F. and Donnez J. (2002c). Iron overload in the peritoneal cavity of women with pelvic endometriosis. Fertil. Steril. 78, 712-718.
106. Van Langendonckt A., Casanas-Roux F., Eggermont J. and Donnez J. (2004). Characterization of iron deposition in endometriotic lesions induced in the nude mouse model. Hum. Reprod. 19, 1265-1271.
107. Veillat V., Lavoie C.H., Metz C.N., Roger T., Labelle Y. and Akoum A. (2009). Involvement of nuclear factor-kB in macrophage migration inhibitory factor gene transcription up-regulation induced by interleukin-1 beta in ectopic endometrial cells. Fertil. Steril. 91, 2148-2156.
108. Vercellini P., De Giorgi O., Aimi G., Panazza S., Uglietti A. and Crosignani P.G. (1997). Menstrual characteristics in women with and without endometriosis. Obstet. Gynecol. 90, 264-268.
109. Viatour P., Merville M.P., Bours V. and Chariot A. (2005). Phosphorylation of NF-κB and IkB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30, 43-52.
110. Wagener F.A., Feldman E., de Witte T. and Abraham N.G. (1997). Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc. Soc. Exp. Biol. Med. 216, 456-63.
111. Weinberg J.B., Haney A.F., Xu F.J. and Ramakrishnan S. (1991). Peritoneal fluid and plasma levels of human macrophage colonystimulating factor in relation to peritoneal fluid macrophage content. Blood 78, 513-516.
112. Wieser F., Cohen M., Gaeddert A., Yu J., Burks-Wicks C., Berga S.L. and Taylor R.N. (2007). Evolution of medical treatment for endometriosis: back to the roots? Hum. Reprod. Update 13, 487-499.
113. Wieser F., Vigne J.L., Ryan I., Hornung D., Djlali S. and Taylor R.N. (2005). Sulindac suppresses nuclear factor-κB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosis. J. Clin. Endocrinol. Metab. 90, 6441-6447.
114. Witz C.A., Cho S., Centonze V.E., Montoya-Rodriguez I.A. and Schenken R.S. (2003). Time series analysis of transmesothelial invasion by endometrial stromal and epithelial cells using three-dimensional confocal microscopy. Fertil. Steril. 79, 770-778.
115. Wu M.Y., Ho H.N., Chen S.U., Chao K.H., Chen C.D. and Yang Y.S. (1999). Increase in the production of interleukin-6, interleukin-10, and interleukin-12 by lipopolysaccharide-stimulated peritoneal macrophages from women with endometriosis. Am. J. Reprod. Immunol. 41, 106-111
116. Xi G., Keep R.F. and Hoff J.T. (2006). Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 5, 53-63.
117. Yagyu T., Kobayashi H., Matsuzaki H., Wakahara K., Kondo T., Kurita N., Sekino H., Inagaki K., Suzuki M., Kanayama N. and Terao T. (2005). Thalidomide inhibits tumor necrosis factor-alpha-induced interleukin-8 (IL-8) expression in endometriotic stromal cells possibly through suppression of nuclear factor-kB activation. J. Clin. Endocrinol. Metab. 90, 3017-3221.
118. Yamaguchi K., Mandai M., Toyokuni S., Hamanishi J., Higuchi T., Takakura K. and Fujii S. (2008). Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin. Cancer Res. 14, 32-40.
119. Yamamoto Y. and Gaynor R.B. (2001). Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107, 135-142.
120. Yamauchi N., Harada T., Taniguchi F., Yoshida S., Iwabe T. and Terakawa N. (2004). Tumor necrosis factor-a induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factorkB and mitogen-activated protein kinase pathways. Fertil. Steril. 82, 1023-1028.
121. Yang Y., Degranpre P., Kharfi A. and Akoum A. (2000). Identification of macrophage migration inhibitory factor as a potent endothelial cell growth-promoting agent released by ectopic human endometrial cells. J. Clin. Endocrinol. Metab. 85, 4721-4727.
122. Yoshida S., Harada T., Mitsunari M., Iwabe T., Sakamoto Y., Tsukihara S., Iba Y., Horie S. and Terakawa N. (2004). Hepatocyte growth factor/Met system promotes endometrial and endometriotic stromal cell invasion via autocrine and paracrine pathways. J. Clin. Endocrinol. Metab. 89, 823-832.